首页 | 本学科首页   官方微博 | 高级检索  
     


Rationale and design of a randomized,double‐blind,placebo‐controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT)
Authors:Karl Swedberg  Michel Komajda  Michael Böhm  Jeffrey S. Borer  Ian Ford  Luigi Tavazzi
Affiliation:1. Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, University of Gothenburg, SE‐416 85 G?teborg, Sweden;2. Department of Cardiology, University Pierre et Marie Curie Paris VI, La Pitié‐Salpétrière Hospital, Paris, France;3. Universit?tskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany;4. Division of Cardiovascular Medicine and the Howard Gilman Institute for Heart Valve Disease, State University of New York Downstate Medical Center, Brooklyn, New York, NY, USA;5. Robertson Centre for Biostatistics, University of Glasgow, Scotland, UK;6. GVM Hospitals of Care and Research, Cotignola, Italy
Abstract:
Keywords:Chronic heart failure  Heart rate  Ivabradine  Randomized trial  Treatment
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号